Effect of medication co-payment vouchers on P2Y12 inhibitor use and major adverse cardiovascular events among patients with myocardial infarction: the ARTEMIS …

TY Wang, LA Kaltenbach, CP Cannon, GC Fonarow… - Jama, 2019 - jamanetwork.com
Importance Despite guideline recommendations, many patients discontinue P2Y 12 inhibitor
therapy earlier than the recommended 1 year after myocardial infarction (MI), and higher …

Difference in Medication Adherence Between Patients Prescribed a 30‐Day Versus 90‐Day Supply After Acute Myocardial Infarction

JA Rymer, E Fonseca, DD Bhandary… - Journal of the …, 2021 - Am Heart Assoc
Background Evidence‐based medication adherence rates after a myocardial infarction are
low. We hypothesized that 90‐day prescriptions are underused and may lead to higher …

Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): a multicenter, cluster …

JA Doll, TY Wang, NK Choudhry, CP Cannon… - American heart …, 2016 - Elsevier
Background The use of oral P2Y 12 receptor inhibitors after acute myocardial infarction (MI)
can reduce risks of subsequent major adverse cardiovascular events (composite of all …

The cost of inpatient death associated with acute coronary syndrome

RL Page, V Ghushchyan, J Van Den Bos… - Vascular health and …, 2016 - Taylor & Francis
Background No studies have addressed the cost of inpatient mortality during an acute
coronary syndrome (ACS) admission. Objective Compare ACS-related length of stay (LOS) …

[HTML][HTML] Hospitalization for myocardial infarction with ticagrelor or clopidogrel in patients with acute coronary syndrome: an on-treatment comparative effectiveness …

T Olufade, N Atreja, N Bhalla, J Venditto… - Cardiology and …, 2021 - Springer
Introduction Prescribing patterns and suboptimal adherence present methodological
challenges for real-world head-to-head comparisons of ticagrelor and clopidogrel in intent-to …

Contemporary incidence of recurrent cardiovascular events 1 to 3 years after myocardial infarction: longitudinal US analysis from NCDR registries linked with all-payer …

J Spertus, D Bhandary, E Fonseca, N Bhalla… - Journal of the American …, 2018 - jacc.org
Background Long-term risks of myocardial infarction (MI) survivors in contemporary US
practice remains severely under recognized. Using a unique linkage of national …

[HTML][HTML] Clinically feasible stratification of 1-year to 3-year post-myocardial infarction risk

BD Horne, JB Muhlestein, D Bhandary, GL Hoetzer… - Open …, 2018 - openheart.bmj.com
Objective Post-myocardial infarction (MI) care is crucial to preventing recurrent major
adverse cardiovascular events (MACE), but can be complicated to personalise. A tool is …

Outcomes of Medicare beneficiaries hospitalised with transient ischaemic attack and stratification using the ABCD2 score

S Shah, L Liang, D Bhandary, S Johansson… - Stroke and vascular …, 2021 - svn.bmj.com
Background Long-term outcomes for Medicare beneficiaries hospitalised with transient
ischaemic attack (TIA) and role of ABCD2 score in identifying high-risk individuals are not …

Translating clinical evidence into value-based payment models: pooled analyses of innovative real-world outcomes agreements for ticagrelor in the United States.

D Bhandary, N Atreja, DA Belletti, N Bhalla… - The American Journal …, 2020 - europepmc.org
Innovative value strategies for reimbursement of medications include value-based
agreements (VBAs) between payers and pharmaceutical manufacturers, which have the …

Difference in medication adherence between patients filling 30-versus 90-day prescription supply after acute myocardial infarction

J Rymer, E Fonseca, D Bhandary, N Khan… - Journal of the American …, 2018 - jacc.org
Background We hypothesize that 90-day prescription fills are underutilized in post-
myocardial infarction (MI) patients and may lead to higher adherence to evidence-based …